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ABSTRACT: Herein we describe biodegradable nanovectors comprised
of block copolymers of poly(ethylene glycol) and poly(trimethylene
carbonate) (PEG−PTMC) that change their morphology and surface
charge when exposed to tumor environment conditions. Well-deﬁned,
drug-loaded nanovectors were prepared via direct hydration using liquid
oligo(ethylene glycol) as a dispersant. Systematic introduction of basic
imidazole-functional TMC derivatives, through modular polymerization,
resulted in polymers that self-assembled in multilamellar nanoparticles
(at neutral pH) and that were loaded with hydrophobic drugs. The
resultant multilamellar nanovectors demonstrated a signiﬁcant size
reduction and charge reversal at pH ≈ 6.5, which yielded cationic nanovectors that were tailored for tumor penetration. In vitro
studies using 3D heterospheroids demonstrate that this platform has excellent potential to promote enhanced tumor
penetration under physiological conditions.
A challenge facing nanomedicine is that the requiredfeatures of drug nanocarriers for sustained circulation in
the body are distinctly diﬀerent from those necessary for
eﬀective drug release at the desired site of action.1−3 Local
application of (noninvasive) physical strategies in order to
enhance the therapeutic eﬃcacy by changing particle proper-
ties only where required provides one possible solution.4−6 A
higher level of precision is achieved if the physical properties
and behavior of nanoparticles are tailored to exploit distinct
features already displayed in the microenvironment of the
targeted tissue,7,8 an approach that is receiving an increasing
amount of attention. In this respect, the tumor microenviron-
ment (TME) is a highly interesting area to exploit.9−12 It is
well-known that the vasculature, pH, and redox conditions of
the TME are considerably diﬀerent compared to healthy tissue,
and many groups have developed strategies to enhance the
therapeutic eﬃcacy of their carrier systems by employing, for
example, pH-sensitive components.9 However, in most cases
the induced trigger leads to a burst release of the drug and not
to changes of the particle features.13,14 In terms of design
criteria, the optimal platform should exist in an uncharged (or
partially negative) form with size <100 nm under neutral
conditions and, as pH decreases, undergo dynamic reconﬁgu-
ration into smaller, cationic particles that can eﬀectively
penetrate into tumor tissue, delivering cytotoxic payload in a
responsive fashion (Figure 1c).15−17
Block copolymers (BCPs) are a highly versatile platform for
the design and engineering of smart nanosystems,18−21 and the
implementation of BCPs toward anticancer therapy has made
signiﬁcant progress.22−28 Still, there is much to be gained by
exploring the morphology and responsiveness of BCP-based
nanosystems to unlock their therapeutic potential.8,25,28 A
signiﬁcant challenge in the engineering of BCP nanosystems is
to maintain functionality while satisfying the fundamental
criterion of biocompatibility.11,29 Few systems exist that
demonstrate biodegradability while responding to overtly
physiological stimuli (such as pH or redox chemistry).30−35
Recognizing the strategic importance of the TME, we have
undertaken to engineer smart biodegradable nanovectors
(NVs) that are capable of undergoing a pH-induced
morphology and surface charge switch in order to direct
tumor internalization and improve penetration. Key to the
success of this strategy is the improved circulation and
distribution of nanoparticles with a negative surface charge
being physicochemically coupled to the enhanced internal-
ization properties of those with smaller size and positive
charge.7,12 This platform constitutes the ﬁrst fully biodegrad-
able, stimuli-responsive system that can undergo pH-induced
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transformation into nanoparticles that demonstrate enhanced
tumor penetration.
Recently, we have presented an approach toward the
fabrication of both drug-loaded NVs and enzyme-loaded
nanoreactors, comprising biodegradable copolymers based on
poly(ethylene glycol)-block-poly(trimethylene carbonate)
(PEG−PTMC) and utilizing direct hydration as a facile,
biocompatible, fabrication process.36,37 PEG−PTMC copoly-
mers provide the necessary structural versatility necessary to
engineer particles that are capable of undergoing dynamic
transformations.29,38−40
pH-responsive functionality was introduced into PEG-
PTMC copolymers using carbonate monomers with a basic
imidazole moiety (TMCI, pKa ≈ 6.5) to create terpolymeric
chains that could induce dynamic reconﬁguration under
conditions similar to the TME (Figure 1a). Using the direct
hydration methodology, self-assembly of PEG−PTMC copoly-
mers comprising TMCI was assessed by systematically varying
the block conﬁguration in order to identify the nexus between
size, stability, and dynamicity (Figure 1b).
PEG−PTMC copolymers with well-deﬁned sequences were
synthesized via the sequential ring-opening polymerization of
TMC and TMC-OPhF5 monomers, with pH-responsive
imidazole moieties introduced by postpolymerization (Scheme
S1).34,41−43 In terms of copolymer design, we evaluated the
eﬀect of TMCI upon the self-assembly and pH-induced
reconﬁguration of particles to identify the optimal composition
that would yield the desired design criteria. As PEG22-PTMC30
BCPs were known to yield well-deﬁned micelles, we used this
as the basis to prepare terpolymers where TMCI occupied
either the terminal or intermediate position (Table S4).
Assessing the terminal PEG-TMC-TMCI copolymers demon-
strated that shorter PTMC blocks (DP = 23 vs 30) did not
display a pronounced size change upon acidic pH incubation,
and longer PTMCI blocks (DP = 10 vs 7) resulted in visible
aggregations (Figure S23). The size change behavior of PEG-
TMC-TMCI BCPs was not optimal at pH 6.5, with 2 h
incubation yielding around 60 nm nanoparticles and no
signiﬁcant size decrease after prolonged incubation (Figure
S24a). Introducing PTMCI in the intermediate terpolymer
position was a more eﬀective strategy. PEG-TMCI-TMC
copolymers also showed a pH-induced size change (130−140
vs 43 nm, at pH 7.4 and 6.5, respectively). We observed a
marked advantage with PEG22-TMCI7-TMC30, which under-
went eﬀective reconﬁguration in 2 h at pH 6.5 toward
nanoparticles of 40 nm, possibly because of improved access to
protonation (compared to PEG-TMC30-TMCI7) and reduced
hydrophilic repulsion (compared to PEG-TMCI10-TMC30)
(Figure S25 and S26).31,40 To highlight the importance of
structural control in directing this pH-responsive behavior, the
random copolymer of TMC and TMCI was prepared. PEG-
(TMC-r-TMCI) BCPs underwent self-assembly under neutral
conditions but disassembled at low pH, with only large (>600
nm), poorly deﬁned particles evident by dynamic light
scattering (DLS) (Figure S27). Nonresponsive TMC-based
polymersomes did not show signiﬁcant size or zeta potential
change when incubated in an acidic buﬀer (Figure S28).37
Having identiﬁed PEG22-TMCI7-TMC30 as an excellent
candidate for the formation of a pH-responsive nanosystem, its
self-assembly was studied in greater detail. Under neutral
conditions, cryo-TEM images showed that the terpolymer
underwent self-assembly into multilamellar nanovectors
(MLNs, Figure 2a/S30), which is consistent with DLS data.
At low pH, MLNs underwent reorganization into cationic
nanovectors (CNs) with micellar morphology (Figure 2b/
S32). Scanning electron microscopy (SEM) further conﬁrmed
the size switch behavior of MLNs (Figure S33). MLN to CN
Figure 1. Schematic illustrating (a) the chemical structure of PEG-
TMCI-TMC terpolymers and the chemical change that occurs
through protonation of imidazole moieties at low pH, (b) fabrication
of drug-loaded multilamellar nanovectors (MLNs) via direct
hydration and the structural reconﬁguration that occurs at low pH
into cationic nanovectors (CNs), and (c) the anticipated mode of
action of MLNs in vivo whereby local pH reduction in the TME leads
to enhanced internalization of CNs and tumor penetration.
Figure 2. pH-induced transformation of multilamellar nanovectors
(MLNs) into cationic nanovectors (CNs) comprising PEG22-TMCI7-
TMC30 terpolymers. TEM images of (a) MLNs and (b) CNs after
reduction in pH (scale bars = 100 nm). AF4 fractogram (scattering
proﬁle in black) of (c) MLNs at pH 7.4 and (d) after transformation
to CNs at pH 5 comparing the radius of gyration (Rg, blue) to the
hydrodynamic radius (Rh, red). (e) Real-time monitoring of the pH-
induced transformation of MLNs by DLS. (f) Zeta-potential
measurements of MLNs/CNs at varying pH.
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transformation is driven by the ﬂexibility of the TMC block
and imidazole protonation, which increased interchain
repulsion and facilitated micellization,30,40 with the resulting
micelles having increasingly cationic character as determined
by zeta-potential measurements (Figure 2f). For quantitative
insight into the particle morphology, we employed asymmetric
ﬂow ﬁeld−ﬂow fractionation (AF4) coupled with multiangle
light scattering (MALS) and DLS. Consistent with cryo-TEM
data, MLNs possessed an average hydrodynamic radius (Rh) of
73.1 nm with particles ranging from 47.2 to 117.4 nm.
Comparing this to the radius of gyration (Rg) yielded a shape
factor (Rg/Rh) of 0.82, consistent with ﬁlled spheres (Figure
2c/S34a). CNs displayed a much more uniform size proﬁle,
with Rh values between 12.8 and 23.4 nm (average 16.6 nm);
moreover, the shape factor 0.74 indicated a micellar
morphology (Figure 2d/S34b). The critical aggregation
concentration (CAC) of MLNs/CNs was determined using
1-anilino-8-naphthalenesulfonate (ANS) assay. Before and
after protonation, CAC values were measured at ca. 0.017
(2.7 μM) and 0.026 mg/mL (4.2 μM), respectively (Figure
S36).
We next monitored the performance of MLNs to undergo
an eﬃcient size switch under increasingly acidic conditions. A
signiﬁcant decrease in particle size was observed within 60 min
at pH values of 5, 6, and 6.5, with no evidence of larger
particles after 4 h (Figure 2e). After only 30 min at pH 6.5,
both morphologies were evident by cryo-TEM as the size
switch from MLNs to CNs was ongoing (Figure S31). AF4
data for MLNs incubated at pH 6.5 for 2 h indicated that the
transformation to CNs was complete, with values of Rh
comparable to those at pH 5 (Figure S35).
In vitro performance of MLNs was studied using HepG2
cells to assess the functional impact of the pH-induced
transformation. Chlorin e6 (Ce6)-labeled MLNs (Scheme S1)
were utilized for ﬂuorescence visualization of particle uptake;
the presence of 2 wt % PEG-PTMC-Ce6 did not aﬀect the
responsive nature of the particles (Figure S29a). After
incubation of the cells with MLNs at pH 6.5, it was clear
from microscopy (Figure 3a/S40) and ﬂow cytometry (Figure
3b/S41) that CNs demonstrated enhanced cellular uptake as
compared to MLNs. Interestingly, this distinct behavior was
already observed after 30 min, which increased further after an
hour as the pH-induced transformation progressed (Figure
S41). Nonresponsive control polymersomes did not show any
change in cellular uptake between normal physiological pH
and acidic conditions (Figure S42). Furthermore, we
conﬁrmed that under these conditions (pH 7.4/6.5) little
toxicity was observed up to [copolymer] = 0.2 mg/mL (≈70%,
Figure S38).
Next, we assessed the capacity of this pH-responsive
platform to deliver cytotoxic cargo and to determine what
eﬀect structural reconﬁguration would have on this process.
Using a hydrophobic cisplatin prodrug (Figure S39a) we
prepared MLNs with 9.3 wt % loading with 93% eﬃciency.44
At lower pH drug was released from CNs more rapidly (ca. 75
and 90% released after 24 h at pH 6.5 and 5.5, respectively) as
compared to MLNs at neutral pH (Figure S39b). Cytotoxicity
was tested against both HeLa and HepG2 cell lines. As with
HepG2 cells, little background toxicity was observed for the
unloaded particles at [copolymer] < 0.2 mg/mL, both at
neutral pH and pH 6.5 (Figure S38). Prodrug cytotoxicity was
enhanced through encapsulation in MLNs against HeLa and
HepG2 cells (HeLa, IC50 free prodrug: 16.0 μM, IC50 prodrug
loaded: 3.3 μM; HepG2, IC50 free prodrug: 10.3 μM, IC50
prodrug loaded: 1.8 μM, Figure 4a/b). At pH 6.5 this eﬀect
was more pronounced (HeLa, IC50 prodrug loaded: 1.5 μM;
HepG2, IC50 prodrug loaded: 0.7 μM), demonstrating the
formation of CNs did not diminish the therapeutic perform-
ance of encapsulated cargo despite the pH-induced structural
reconﬁguration.
Figure 3. MLN performance in vitro. (a) Fluorescent images of
HepG2 cells treated with Ce6-labeled MLNs for 2 h at pH 7.4 and 6.5
(scale bar = 20 μm). (b) Flow cytometry results for uptake into
HepG2 cells at pH 7.4 (gray) and 6.5 (red) compared to control cells
(light gray).
Figure 4. MLN performance in vitro. Cell viability of (a) HeLa and
(b) HepG2 cells after treatment with free cisplatin prodrug (blue) and
drug-loaded MLNs at pH 7.4 (black) and 6.5 (red).
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Lastly, to determine whether this behavior would translate to
a more biologically relevant platform we studied multicellular
spheroids (MCSs) as tumor models in vitro.35,45 Using
confocal laser scanning microscopy (CLSM) stack imaging it
was apparent that after 2 h MLNs (at pH 7.4) were principally
located on the periphery of MCSs with a penetration depth of
40−60 μm, whereas CNs (at pH 6.5) showed enhanced
penetration (Figure S43). After 18 h incubation, although
MLNs (at pH 7.4) did not show a signiﬁcant change in the
penetration proﬁle, CNs (at pH 6.5) showed signiﬁcantly
enhanced penetration to depths of 180 μm (Figure 5a/b, S44).
Similar results were obtained with penetration studies on
heterospheroids, comprising a mixture of HepG2 cells and
ﬁbroblast 3T3 cells (1:5) (Figure S45).45 As a further control,
we conﬁrmed that nonresponsive polymersomes did not
undergo any increase in penetration at lower pH (Figure
S46/S47). These results suggest that the pH-induced trans-
formation of MLNs into CNs can enhance tumor penetration
under physiological conditions and that this pH-responsive
MLN/CN system can be an eﬀective strategy for the treatment
of cancer.
In summary, we present biodegradable BCP assemblies with
pH-responsive behavior such that, at low pH, a morphology
switch occurs resulting in the formation of highly penetrating
cationic nanovectors. This is achieved by implementing
imidazole-modiﬁed domains (pKa ≈ 6.5) in the ﬂexible
polycarbonates, which induce the alteration of amphiphilicity
and charge under pH conditions alike to the tumor
microenvironment. The dynamic morphology and surface
charge modulation of these biodegradable nanovectors provide
desirable physicochemical features that could enable targeted
delivery and deeper penetration in tumor tissue.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acsmacro-
lett.8b00807.
Included are details of materials, methods, synthesis, and
other supporting data utilized in this work (PDF)
■ AUTHOR INFORMATION
Corresponding Authors
*Jan C. M. van Hest (j.c.m.v.hest@tue.nl).
*David S. Williams (d.s.williams@swansea.ac.uk).
ORCID
Loai K. E. A. Abdelmohsen: 0000-0002-0094-1893
Enrico Mastrobattista: 0000-0002-6745-2015
David S. Williams: 0000-0002-8209-6899
Jan C. M. van Hest: 0000-0001-7973-2404
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
The authors would like to acknowledge the ERC Advanced
Grant Artisym 694120, the Dutch Ministry of Education,
Culture and Science (Gravitation program 024.001.035), and
the European Union’s Horizon 2020 research and innovation
programme Marie Sklodowska-Curie Innovative Training
Networks Nanomed (No. 676137) for funding. We thank
the Ser Cymru II programme for support of DSW; this project
received funding from the European Union’s Horizon 2020
research and innovation programme under the Marie
Skłodowska-Curie grant agreement No. 663830. We would
also like to thank Imke Pijpers and Alex Mason for help with
Cryo-TEM measurements.
■ REFERENCES
(1) Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.;
Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy.
Nat. Nanotechnol. 2007, 2, 751.
(2) Sanhai, W. R.; Sakamoto, J. H.; Canady, R.; Ferrari, M. Seven
Challenges for Nanomedicine. Nat. Nanotechnol. 2008, 3, 242−244.
(3) Davis, M. E.; Chen, Z.; Shin, D. M. Nanoparticle Therapeutics:
An Emerging Treatment Modality for Cancer. Nat. Rev. Drug
Discovery 2008, 7, 771−782.
(4) Petros, R. A.; DeSimone, J. M. Strategies in the Design of
Nanoparticles for Therapeutic Applications. Nat. Rev. Drug Discovery
2010, 9, 615.
(5) Torchilin, V. P. Multifunctional, Stimuli-Sensitive Nano-
particulate Systems for Drug Delivery. Nat. Rev. Drug Discovery
2014, 13, 813.
(6) Blanco, E.; Shen, H.; Ferrari, M. Principles of Nanoparticle
Design for Overcoming Biological Barriers To Drug Delivery. Nat.
Biotechnol. 2015, 33, 941−951.
(7) Cheng, R.; Meng, F.; Deng, C.; Zhong, Z. Bioresponsive
Polymeric Nanotherapeutics for Targeted Cancer Chemotherapy.
Nano Today 2015, 10, 656−670.
(8) Mura, S.; Nicolas, J.; Couvreur, P. Stimuli-Responsive Nano-
carriers for Drug Delivery. Nat. Mater. 2013, 12, 991.
(9) Mo, R.; Gu, Z. Tumor Microenvironment and Intracellular
Signal-Activated Nanomaterials for Anticancer Drug Delivery. Mater.
Today 2016, 19, 274−283.
(10) Wang, Y.; Zhou, K.; Huang, G.; Hensley, C.; Huang, X.; Ma,
X.; Zhao, T.; Sumer, B. D.; DeBerardinis, R. J.; Gao, J. A
Nanoparticle-Based Strategy for the Imaging of a Broad Range of
Figure 5. MLN performance in vitro. (a) Fluorescent images
following penetration into 3D MCSs at pH 7.4 and 6.5 (scale bar =
200 μm). (b) Quantiﬁcation of ﬂuorescent data in (c) after 18 h of
treatment.
ACS Macro Letters Letter
DOI: 10.1021/acsmacrolett.8b00807
ACS Macro Lett. 2018, 7, 1394−1399
1397
Tumours by Nonlinear Amplification of Microenvironment Signals.
Nat. Mater. 2014, 13, 204.
(11) Dai, Y.; Xu, C.; Sun, X.; Chen, X. Nanoparticle Design
Strategies for Enhanced Anticancer Therapy by Exploiting the
Tumour Microenvironment. Chem. Soc. Rev. 2017, 46, 3830−3852.
(12) Feng, L.; Dong, Z.; Tao, D.; Zhang, Y.; Liu, Z. The Acidic
Tumor Microenvironment: A Target for Smart Cancer Nano-
Theranostics. Natl. Sci. Rev. 2018, 5, 269−286.
(13) Yang, K.; Chang, Y.; Wen, J.; Lu, Y.; Pei, Y.; Cao, S.; Wang, F.;
Pei, Z. Supramolecular Vesicles Based on Complex of Trp-Modified
Pillar[5]arene and Galactose Derivative for Synergistic and Targeted
Drug Delivery. Chem. Mater. 2016, 28, 1990−1993.
(14) Cao, S.; Pei, Z.; Xu, Y.; Pei, Y. Glyco-Nanovesicles with
Activatable Near-Infrared Probes for Real-Time Monitoring of Drug
Release and Targeted Delivery. Chem. Mater. 2016, 28, 4501−4506.
(15) Wang, J.; Mao, W.; Lock, L. L.; Tang, J.; Sui, M.; Sun, W.; Cui,
H.; Xu, D.; Shen, Y. The Role of Micelle Size in Tumor
Accumulation, Penetration, and Treatment. ACS Nano 2015, 9,
7195−7206.
(16) Sun, Q.; Sun, X.; Ma, X.; Zhou, Z.; Jin, E.; Zhang, B.; Shen, Y.;
Van Kirk, E. A.; Murdoch, W. J.; Lott, J. R.; Lodge, T. P.; Radosz, M.;
Zhao, Y. Integration of Nanoassembly Functions for an Effective
Delivery Cascade for Cancer Drugs. Adv. Mater. 2014, 26, 7615−
7621.
(17) Tang, L.; Yang, X.; Yin, Q.; Cai, K.; Wang, H.; Chaudhury, I.;
Yao, C.; Zhou, Q.; Kwon, M.; Hartman, J. A.; Dobrucki, I. T.;
Dobrucki, L. W.; Borst, L. B.; Lezmi, S.; Helferich, W. G.; Ferguson,
A. L.; Fan, T. M.; Cheng, J. Investigating the Optimal Size of
Anticancer Nanomedicine. Proc. Natl. Acad. Sci. U. S. A. 2014, 111,
15344−15349.
(18) Mai, Y.; Eisenberg, A. Self-Assembly of Block Copolymers.
Chem. Soc. Rev. 2012, 41, 5969−5985.
(19) van Dongen, S. F. M.; de Hoog, H.-P. M.; Peters, R. J. R. W.;
Nallani, M.; Nolte, R. J. M.; van Hest, J. C. M. Biohybrid Polymer
Capsules. Chem. Rev. 2009, 109, 6212−6274.
(20) Wiradharma, N.; Zhang, Y.; Venkataraman, S.; Hedrick, J. L.;
Yang, Y. Y. Self-Assembled Polymer Nanostructures for Delivery of
Anticancer Therapeutics. Nano Today 2009, 4, 302−317.
(21) Kim, S. H.; Nederberg, F.; Jakobs, R.; Tan, J. P. K.; Fukushima,
K.; Nelson, A.; Meijer, E. W.; Yang, Y. Y.; Hedrick, J. L. A
Supramolecularly Assisted Transformation of Block-Copolymer
Micelles into Nanotubes. Angew. Chem., Int. Ed. 2009, 48, 4508−
4512.
(22) Shi, Y.; van der Meel, R.; Theek, B.; Oude Blenke, E.; Pieters,
E. H. E.; Fens, M. H. A. M.; Ehling, J.; Schiffelers, R. M.; Storm, G.;
van Nostrum, C. F.; Lammers, T.; Hennink, W. E. Complete
Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel
via Π−Π Stacking Stabilized Polymeric Micelles. ACS Nano 2015, 9,
3740−3752.
(23) Wang, S.; Huang, P.; Chen, X. Hierarchical Targeting Strategy
for Enhanced Tumor Tissue Accumulation/Retention and Cellular
Internalization. Adv. Mater. 2016, 28, 7340−7364.
(24) Xu, X.; Wu, J.; Liu, Y.; Yu, M.; Zhao, L.; Zhu, X.; Bhasin, S.; Li,
Q.; Ha, E.; Shi, J.; Farokhzad Omid, C. Ultra-pH-Responsive and
Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with
Robust Anti-Cancer Efficacy. Angew. Chem., Int. Ed. 2016, 55, 7091−
7094.
(25) Fukushima, K.; Tan, J. P. K.; Korevaar, P. A.; Yang, Y. Y.;
Pitera, J.; Nelson, A.; Maune, H.; Coady, D. J.; Frommer, J. E.; Engler,
A. C.; Huang, Y.; Xu, K.; Ji, Z.; Qiao, Y.; Fan, W.; Li, L.; Wiradharma,
N.; Meijer, E. W.; Hedrick, J. L. Broad-Spectrum Antimicrobial
Supramolecular Assemblies with Distinctive Size and Shape. ACS
Nano 2012, 6, 9191−9199.
(26) Abdelmohsen, L. K. E. A.; Williams, D. S.; Pille, J.; Ozel, S. G.;
Rikken, R. S. M.; Wilson, D. A.; van Hest, J. C. M. Formation of Well-
Defined, Functional Nanotubes via Osmotically Induced Shape
Transformation of Biodegradable Polymersomes. J. Am. Chem. Soc.
2016, 138, 9353−9356.
(27) Pijpers, I. A. B.; Abdelmohsen, L. K. E. A.; Williams, D. S.; van
Hest, J. C. M. Morphology Under Control: Engineering Biodegrad-
able Stomatocytes. ACS Macro Lett. 2017, 6, 1217−1222.
(28) Williams, D. S.; Pijpers, I. A. B.; Ridolfo, R.; van Hest, J. C. M.
Controlling the Morphology of Copolymeric Vectors for Next
Generation Nanomedicine. J. Controlled Release 2017, 259, 29−39.
(29) Deng, C.; Jiang, Y.; Cheng, R.; Meng, F.; Zhong, Z.
Biodegradable Polymeric Micelles for Targeted and Controlled
Anticancer Drug Delivery: Promises, Progress and Prospects. Nano
Today 2012, 7, 467−480.
(30) Yan, Q.; Zhao, Y. Polymeric Microtubules That Breathe: CO2-
Driven Polymer Controlled-Self-Assembly and Shape Transformation.
Angew. Chem., Int. Ed. 2013, 52, 9948−9951.
(31) Yan, Q.; Zhao, Y. CO2-Stimulated Diversiform Deformations
of Polymer Assemblies. J. Am. Chem. Soc. 2013, 135, 16300−16303.
(32) Che, H.; Cao, S.; van Hest, J. C. M. Feedback-Induced
Temporal Control of “Breathing” Polymersomes To Create Self-
Adaptive Nanoreactors. J. Am. Chem. Soc. 2018, 140, 5356−5359.
(33) Qi, W.; Zhang, Y.; Wang, J.; Tao, G.; Wu, L.; Kochovski, Z.;
Gao, H.; Chen, G.; Jiang, M. Deprotection-Induced Morphology
Transition and Immunoactivation of Glycovesicles: A Strategy of
Smart Delivery Polymersomes. J. Am. Chem. Soc. 2018, 140, 8851−
8857.
(34) Chan, J. M. W.; Tan, J. P. K.; Engler, A. C.; Ke, X.; Gao, S.;
Yang, C.; Sardon, H.; Yang, Y. Y.; Hedrick, J. L. Organocatalytic
Anticancer Drug Loading of Degradable Polymeric Mixed Micelles via
a Biomimetic Mechanism. Macromolecules 2016, 49, 2013−2021.
(35) Chen, J.; Ding, J.; Wang, Y.; Cheng, J.; Ji, S.; Zhuang, X.; Chen,
X. Sequentially Responsive Shell-Stacked Nanoparticles for Deep
Penetration into Solid Tumors. Adv. Mater. 2017, 29, 1701170.
(36) Ridolfo, R.; Ede, B. C.; Diamanti, P.; White, P. B.; Perriman, A.
W.; van Hest, J. C. M.; Blair, A.; Williams, D. S. Biodegradable, Drug-
Loaded Nanovectors via Direct Hydration as a New Platform for
Cancer Therapeutics. Small 2018, 14, 1703774.
(37) van Oppen, L. M. P. E.; Abdelmohsen, L. K. E. A.; van Emst-de
Vries, S. E.; Welzen, P. L. W.; Wilson, D. A.; Smeitink, J. A. M.;
Koopman, W. J. H.; Brock, R.; Willems, P. H. G. M.; Williams, D. S.;
van Hest, J. C. M. Biodegradable Synthetic Organelles Demonstrate
ROS Shielding in Human-Complex-I-Deficient Fibroblasts. ACS Cent.
Sci. 2018, 4, 917−928.
(38) Fukushima, K. Poly(trimethylene carbonate)-Based Polymers
Engineered for Biodegradable Functional Biomaterials. Biomater. Sci.
2016, 4, 9−24.
(39) Chen, W.; Meng, F.; Cheng, R.; Deng, C.; Feijen, J.; Zhong, Z.
Advanced Drug and Gene Delivery Systems Based on Functional
Biodegradable Polycarbonates and Copolymers. J. Controlled Release
2014, 190, 398−414.
(40) Nederberg, F.; Zhang, Y.; Tan, J. P. K.; Xu, K.; Wang, H.; Yang,
C.; Gao, S.; Guo, X. D.; Fukushima, K.; Li, L.; Hedrick, J. L.; Yang, Y.-
Y. Biodegradable Nanostructures with Selective Lysis of Microbial
Membranes. Nat. Chem. 2011, 3, 409.
(41) Kamber, N. E.; Jeong, W.; Waymouth, R. M.; Pratt, R. C.;
Lohmeijer, B. G. G.; Hedrick, J. L. Organocatalytic Ring-Opening
Polymerization. Chem. Rev. 2007, 107, 5813−5840.
(42) Sanders, D. P.; Fukushima, K.; Coady, D. J.; Nelson, A.;
Fujiwara, M.; Yasumoto, M.; Hedrick, J. L. A Simple and Efficient
Synthesis of Functionalized Cyclic Carbonate Monomers Using a
Versatile Pentafluorophenyl Ester Intermediate. J. Am. Chem. Soc.
2010, 132, 14724−14726.
(43) Chan, J. M. W.; Ke, X.; Sardon, H.; Engler, A. C.; Yang, Y. Y.;
Hedrick, J. L. Chemically Modifiable N-heterocycle-Functionalized
Polycarbonates as a Platform for Diverse Smart Biomimetic
Nanomaterials. Chem. Sci. 2014, 5, 3294−3300.
(44) Dhar, S.; Gu, F. X.; Langer, R.; Farokhzad, O. C.; Lippard, S. J.
Targeted Delivery of Cisplatin to Prostate Cancer Cells by Aptamer
Functionalized Pt(IV) Prodrug-PLGA−PEG Nanoparticles. Proc.
Natl. Acad. Sci. U. S. A. 2008, 105, 17356−17361.
(45) Priwitaningrum, D. L.; Blonde,́ J.-B. G.; Sridhar, A.; van
Baarlen, J.; Hennink, W. E.; Storm, G.; Le Gac, S.; Prakash, J. Tumor
ACS Macro Letters Letter
DOI: 10.1021/acsmacrolett.8b00807
ACS Macro Lett. 2018, 7, 1394−1399
1398
Stroma-Containing 3D Spheroid Arrays: A Tool to Study Nano-
particle Penetration. J. Controlled Release 2016, 244, 257−268.
ACS Macro Letters Letter
DOI: 10.1021/acsmacrolett.8b00807
ACS Macro Lett. 2018, 7, 1394−1399
1399
